{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:13:34Z","timestamp":1776154414072,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672606"],"award-info":[{"award-number":["81672606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2022MH206"],"award-info":[{"award-number":["ZR2022MH206"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01650-1","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:15:25Z","timestamp":1748438125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mutational analysis and protein expression of PI3K\/AKT pathway in four mucinous cystadenocarcinoma of the breast"],"prefix":"10.1186","volume":"20","author":[{"given":"Yan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"1650_CR1","unstructured":"WHO. WHO Classification of Tumours Editorial Board. Breast Tumours. Vol 2. 5th Ed. Lyon, France: IARC. 2019."},{"issue":"1","key":"1650_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00000478-198401000-00003","volume":"8","author":"PP Rosen","year":"1984","unstructured":"Rosen PP, Scott M. Cystic hypersecretory duct carcinoma of the breast. Am J Surg Pathol. 1984;8(1):31\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1650_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00000478-199806000-00006","volume":"22","author":"C Koenig","year":"1998","unstructured":"Koenig C, Tavassoli FA. Mucinous cystadenocarcinoma of the breast. Am J Surg Pathol. 1998;22(6):698\u2013703.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1650_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan PH, Ellis I, Allison K, et al. WHO classification of tumours editorial board. The 2019 world health organization classification of tumours of the breast. Histopathology. 2020;77(2):181\u20135.","journal-title":"Histopathology"},{"issue":"7","key":"1650_CR5","doi-asserted-by":"publisher","first-page":"a025791","DOI":"10.1101\/cshperspect.a025791","volume":"9","author":"SE Levy","year":"2019","unstructured":"Levy SE, Boone BE. Next-Generation sequencing strategies. Cold Spring Harb Perspect Med. 2019;9(7):a025791.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"1650_CR6","first-page":"2562","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Li Y, Zhao P, et al. Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature. Int J Clin Exp Pathol. 2020;13(10):2562\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1650_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10549-024-07357-z","volume":"207","author":"SA Anderson","year":"2024","unstructured":"Anderson SA, Bartow BB, Harada S, et al. p53 protein expression patterns associated with TP53 mutations in breast carcinoma. Breast Cancer Res Treat. 2024;207(1):213\u201322.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1650_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13058-019-1154-8","volume":"21","author":"Y Xing","year":"2019","unstructured":"Xing Y, Lin NU, Maurer MA, et al. Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and\/or PTEN loss\/pten mutation. Breast Cancer Res. 2019;21(1):78.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1650_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/his.15073","volume":"84","author":"WY Chen","year":"2024","unstructured":"Chen WY, Hu YH, Tsai YH, et al. Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations. Histopathology. 2024;84(3):550\u20135.","journal-title":"Histopathology"},{"issue":"3","key":"1650_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000535649","volume":"47","author":"Y Gong","year":"2024","unstructured":"Gong Y, Geng X, Liu Y, et al. Mucinous cystadenocarcinoma of the breast with bone metastases: first case report and literature review. Oncol Res Treat. 2024;47(3):97\u2013103.","journal-title":"Oncol Res Treat"},{"issue":"9","key":"1650_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/tbj.14265","volume":"27","author":"LH Lin","year":"2021","unstructured":"Lin LH, Hernandez O, Zhu K, et al. Genetic profile of primary mucinous cystadenocarcinoma of the breast-A case report. Breast J. 2021;27(9):731\u20134.","journal-title":"Breast J"},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.breast.2020.07.010","volume":"53","author":"K Lu","year":"2020","unstructured":"Lu K, Wang X, Zhang W, et al. Clinicopathological and genomic features of breast mucinous carcinoma. Breast. 2020;53:130\u20137.","journal-title":"Breast"},{"issue":"8","key":"1650_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/1066896918775810","volume":"26","author":"A Nayak","year":"2018","unstructured":"Nayak A, Bleiweiss IJ, Dumoff K, et al. Mucinous cystadenocarcinoma of the breast: report of 2 cases including one with Long-Term local recurrence. Int J Surg Pathol. 2018;26(8):749\u201357.","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"1650_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of Triple-Negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"issue":"7605","key":"1650_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47\u201354.","journal-title":"Nature"},{"issue":"7418","key":"1650_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"1","key":"1650_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-023-01302-2","volume":"18","author":"T Lei","year":"2023","unstructured":"Lei T, Shi YQ, Chen TB. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review. Diagn Pathol. 2023;18(1):13.","journal-title":"Diagn Pathol"},{"issue":"1","key":"1650_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/biomedicines11010109","volume":"11","author":"K Cerma","year":"2023","unstructured":"Cerma K, Piacentini F, Moscetti L, et al. Targeting PI3K\/AKT\/mTOR pathway in breast cancer: from biology to clinical challenges. Biomedicines. 2023;11(1):109.","journal-title":"Biomedicines"},{"issue":"3","key":"1650_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, Chang MT, Xu G, et al. The genomic landscape of Endocrine-Resistant advanced breast cancers. Cancer Cell. 2018;34(3):427\u2013e4386.","journal-title":"Cancer Cell"},{"issue":"37","key":"1650_CR20","doi-asserted-by":"publisher","first-page":"60712","DOI":"10.18632\/oncotarget.10858","volume":"7","author":"D Massihnia","year":"2016","unstructured":"Massihnia D, Galvano A, Fanale D, et al. Triple negative breast cancer: shedding light onto the role of pi3k\/akt\/mtor pathway. Oncotarget. 2016;7(37):60712\u201322.","journal-title":"Oncotarget"},{"issue":"8","key":"1650_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9(8):550\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1650_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"3","key":"1650_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.annonc.2019.11.006","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele F, Stefanovska B, Lusque A, et al. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer. Ann Oncol. 2020;31(3):377\u201386.","journal-title":"Ann Oncol"},{"issue":"14","key":"1650_CR24","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/cancers13143445","volume":"13","author":"A Basu","year":"2021","unstructured":"Basu A, Lambring CB. Akt isoforms: A family affair in breast Cancer. Cancers (Basel). 2021;13(14):3445.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1650_CR25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41467-020-15943-0","volume":"11","author":"KL Post","year":"2020","unstructured":"Post KL, Belmadani M, Ganguly P, et al. Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction. Nat Commun. 2020;11(1):2073.","journal-title":"Nat Commun"},{"issue":"2","key":"1650_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.2407","volume":"216","author":"B Weigelt","year":"2008","unstructured":"Weigelt B, Horlings HM, Kreike B, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216(2):141\u201350.","journal-title":"J Pathol"},{"issue":"1","key":"1650_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","volume":"27","author":"JYS Tsang","year":"2020","unstructured":"Tsang JYS, Tse GM. Molecular classification of breast Cancer. Adv Anat Pathol. 2020;27(1):27\u201335.","journal-title":"Adv Anat Pathol"},{"issue":"Suppl 5","key":"1650_CR28","doi-asserted-by":"publisher","first-page":"S503","DOI":"10.21037\/tcr.2019.06.50","volume":"8","author":"G Botti","year":"2019","unstructured":"Botti G, Cantile M, Collina F, et al. Morphological and pathological features of basal-like breast cancer. Transl Cancer Res. 2019;8(Suppl 5):S503\u20139.","journal-title":"Transl Cancer Res"},{"key":"1650_CR29","doi-asserted-by":"crossref","unstructured":"Cardoni A, De Vito R, Milano GM, et al. A pediatric case of High-Grade secretory carcinoma of the maxillary sinus with ETV6::NTRK3 gene fusion, therapeutic implications, and review of the literature. Pediatr Dev Pathol. 2023 Jan-Feb;26(1):59\u201364.","DOI":"10.1177\/10935266221138706"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01650-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:15:26Z","timestamp":1748438126000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01650-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01650-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have disclosed that they have no significant relationships with or financial interest in any commercial companies pertaining to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"68"}}